Skip to content
10-Q

Quarterly Report

Stoke Therapeutics, Inc. STOK

0001193125-25-264720

← back to feed
Filed
Nov 4, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 57.12M sh
Shares Diluted Q3 2025 · Sep 30, 2025 58.61M sh
Shares Diluted Q3 2025 · Sep 30, 2025 60.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 56.34M sh
Shares Diluted Q3 2025 · Sep 30, 2024 52.99M sh
Capex Q3 2025 · Sep 30, 2025 $438K
Capex Q3 2025 · Sep 30, 2024 $161K
Operating Cash Flow Q3 2025 · Sep 30, 2025 $76.04M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$63.66M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $83.39M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $127.98M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $150.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 $308.11M
Stockholders Equity Q3 2025 · Jun 30, 2025 $334.94M
Stockholders Equity Q3 2025 · Mar 31, 2025 $350.07M
Stockholders Equity Q3 2025 · Dec 31, 2024 $229.02M
Stockholders Equity Q3 2025 · Sep 30, 2024 $232.11M
Stockholders Equity Q3 2025 · Jun 30, 2024 $242.71M
Stockholders Equity Q3 2025 · Mar 31, 2024 $140.34M
Stockholders Equity Q3 2025 · Dec 31, 2023 $159.57M
Current Liabilities Q3 2025 · Sep 30, 2025 $41.73M
Current Liabilities Q3 2025 · Dec 31, 2024 $40.06M
Total Liabilities Q3 2025 · Sep 30, 2025 $52.16M
Total Liabilities Q3 2025 · Dec 31, 2024 $42.53M
Current Assets Q3 2025 · Sep 30, 2025 $272.44M
Current Assets Q3 2025 · Dec 31, 2024 $232.76M
Total Assets Q3 2025 · Sep 30, 2025 $360.26M
Total Assets Q3 2025 · Dec 31, 2024 $271.56M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.65
Eps Diluted Q3 2025 · Sep 30, 2025 $0.85
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.47
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.48
Eps Basic Q3 2025 · Sep 30, 2025 −$0.65
Eps Basic Q3 2025 · Sep 30, 2025 $0.88
Eps Basic Q3 2025 · Sep 30, 2024 −$0.47
Eps Basic Q3 2025 · Sep 30, 2024 −$1.48
Sga Expense Q3 2025 · Sep 30, 2025 $16.03M
Sga Expense Q3 2025 · Sep 30, 2025 $45.94M
Sga Expense Q3 2025 · Sep 30, 2024 $12.69M
Sga Expense Q3 2025 · Sep 30, 2024 $35.95M
Rd Expense Q3 2025 · Sep 30, 2025 $37.7M
Rd Expense Q3 2025 · Sep 30, 2025 $96.23M
Rd Expense Q3 2025 · Sep 30, 2024 $22.21M
Rd Expense Q3 2025 · Sep 30, 2024 $65.71M
Net Income Q3 2025 · Sep 30, 2025 −$38.35M
Net Income Q3 2025 · Sep 30, 2025 $51.05M
Net Income Q3 2025 · Jun 30, 2025 −$23.48M
Net Income Q3 2025 · Mar 31, 2025 $112.88M
Net Income Q3 2025 · Sep 30, 2024 −$26.43M
Net Income Q3 2025 · Sep 30, 2024 −$78.5M
Net Income Q3 2025 · Jun 30, 2024 −$25.7M
Net Income Q3 2025 · Mar 31, 2024 −$26.37M
Operating Income Q3 2025 · Sep 30, 2025 −$43.09M
Operating Income Q3 2025 · Sep 30, 2025 $40.85M
Operating Income Q3 2025 · Sep 30, 2024 −$30M
Operating Income Q3 2025 · Sep 30, 2024 −$87.72M
Revenue Q3 2025 · Sep 30, 2025 $10.63M
Revenue Q3 2025 · Sep 30, 2025 $183.02M
Revenue Q3 2025 · Sep 30, 2024 $4.89M
Revenue Q3 2025 · Sep 30, 2024 $13.94M